DTZ: Oxygenator, Cardiopulmonary Bypass
What it covers
A cardiopulmonary bypass oxygenator is a device used to exchange gases between blood and a gaseous environment to satisfy the gas exchange needs of a patient during open-heart surgery.
The identification in 21 CFR 870.4350, cardiopulmonary bypass oxygenator. FDA gives DTZ no definition of its own, so the regulation’s describes it.
FDA flags DTZ devices as life-sustaining or life-supporting.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261438 | HORIZON 8AF (Integrated OXY MODULE 8AF and Horizon CVR) (US5305) | Eurosets S.R.L | Sep 14, 2026 | Traditional |
| K253838 | Lifemotion Disposable Membrane Oxygenator | Lifemotion Medical Technology Co., Ltd. | Mar 16, 2026 | Traditional |
| K240934 | Quantum Perfusion Blood Oxygenator ECC VT160-E3 (VT160-E3); Quantum Perfusion Blood Oxygenator ECC VT200-E3 (VT200-E3); Quantum Perfusion Blood Oxygenator VT75- E3 (VT75- E3); | Spectrum Medical S.R.L. | Mar 12, 2026 | Traditional |
| K250821 | Horizon AF Plus System (Integrated A.L. One AF Plus OXYGENATOR and Horizon CVR) (US5300); A.L. One AF Plus OXYGENATOR (US5204); Horizon CVR (US5073) | Eurosets S.R.L | Dec 12, 2025 | Traditional |
| K242503 | Trilly Pediatric Oxygenator with Integrated Arterial Filter (US5232) | Eurosets S.R.L | Nov 24, 2025 | Traditional |
| K231982 | Quantum Perfusion Blood Oxygenator VT75-E1, Quantum Perfusion Blood Oxygenator VT75-E2 | Qura S.R.L | Sep 12, 2024 | Traditional |
| K240666 | Affinity Fusion Oxygenator with Integrated Arterial Filter and Balance Biosurface (BB811); Affinity Fusion Oxygenator with Integrated Arterial Filter and Cardiotomy/Venous Reservoir with Balance Biosurface (BB841); Affinity Fusion Oxygenator with Integrated Arterial Filter and Balance Biosurface NON STERILE (BB811-NS) | Medtronic Perfusion Systems | Jul 10, 2024 | Traditional |
| K241352 | Affinity NT Oxygenator and Uncoated Cardiotomy/ Venous Reservoir (541); Affinity NT Oxygenator with Balance Biosurface and Uncoated Cardiotomy/Venous Reservoir (541B) | Medtronic, Inc. | Jun 12, 2024 | Special |
| K231652 | D100 KIDS; D101 KIDS | Sorin Group Italia S.R.L. | Nov 16, 2023 | Special |
| K231773 | Quantum Perfusion Blood Oxygenator with Integrated AF and Sensor VT75-C1U, Quantum Perfusion Blood Oxygenator with Integrated AF VT75-C2U, Quantum Perfusion Blood Oxygenator with Integrated AF and Sensor VT200-C1U, Quantum Perfusion Blood Oxygenator with Integrated AF VT200-C2U, Quantum Perfusion Blood Oxygenator with Integrated AF and Sensor VT160-C1U | Qura S.R.L | Nov 8, 2023 | Traditional |
Clearances by year
74 DTZ 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 3 | 137 |
| 2025 | 2 | 364 |
| 2024 | 3 | 124 |
| 2023 | 5 | 145 |
| 2022 | 2 | 153 |
| 2021 | 5 | 336 |
| 2020 | 5 | 93 |
| 2019 | 5 | 90 |
| 2018 | 3 | 72 |
| 2017 | 2 | 54 |
| 2016 | 3 | 62 |
| 2015 | 9 | 134 |
| 2014 | 5 | 28 |
| 2013 | 9 | 28 |
| 2012 | 9 | 90 |
| 2011 | 4 | 160 |
Who submits
18 applicants cleared a DTZ device since 2011. 61% of the clearances went to applicants in United States, then Italy (27%), Germany (5%) and United Kingdom (4%). By type: Traditional 62% and Special 38%.
| Applicant | Clearances since 2011 |
|---|---|
| Sorin Group Italia S.R.L. | 17 |
| Medtronic, Inc. | 15 |
| Eurosets S.R.L | 7 |
| Terumo Cardiovascular Systems Corporation | 6 |
| Maquet Cardiopulmonary, AG | 5 |
| Qura S.R.L | 4 |
| Chalice Medical , Ltd. | 3 |
| Medos Medizintechnik AG | 3 |
How FDA classifies it
Class II (special controls). The special control for this device is the FDA guidance document entitled “Guidance for Cardiopulmonary Bypass Oxygenators 510(k) Submissions.”
From 21 CFR 870.4350. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 870.4350 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DTZ clearances declared.
Ask about DTZ
Questions about DTZ
What is FDA product code DTZ?
Product code DTZ, “Oxygenator, Cardiopulmonary Bypass” in FDA's classification database, is a Class II device type under 21 CFR 870.4350 (cardiopulmonary bypass oxygenator), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 255 clearances under DTZ, 74 of them since 2011.
How many 510(k) clearances are there under DTZ?
FDA’s 510(k) database listed 255 clearances under DTZ as of Oct 29, 2026, 74 of them decided since 2011; the most recent decision was Sep 14, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a DTZ 510(k)?
For the 5 DTZ clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 269 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DTZ clearances?
Since 2011: Sorin Group Italia S.R.L. (17), Medtronic, Inc. (15), Eurosets S.R.L (7), Terumo Cardiovascular Systems Corporation (6) and Maquet Cardiopulmonary, AG (5). 18 applicants have cleared a DTZ device in that time.